UBS Maintains Neutral on QuidelOrtho, Lowers Price Target to $29

Benzinga · 05/08 18:49
UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $45 to $29.